Transcriptomic and single-cell sequencing identify lipotoxicity-related COPD biomarkers APRT and S100A8, validated by RT-qPCR and a nomogram
Using COPD-related datasets from a public database, this study applied differential expression analysis, machine learning, and gene expression analysis to identify APRT and S100A8 as lipotoxicity-related COPD biomarkers (APRT notably lower and S100A8 notably higher in COPD samples), supported by RT-qPCR, built and validated a nomogram for predicting COPD risk (P = 0.395 in the Hosmer-Lemeshow test), found both biomarkers co-enriched in the "focal adhesion" pathway and significantly correlated with neutrophils, predicted 27 drugs targeting APRT (such as alteplase and relaxin) and methotrexate targeting S100A8, and used scRNA-seq to identify macrophages as a key cell type in COPD with dynamic expression patterns of both biomarkers during macrophage differentiation.